ABPRO HOLDINGS INC (ABP) Fundamental Analysis & Valuation
NASDAQ:ABP • US0008472021
Current stock price
0.522 USD
-0.28 (-34.76%)
At close:
0.28 USD
-0.24 (-46.36%)
After Hours:
This ABP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABP Profitability Analysis
1.1 Basic Checks
- In the past year ABP has reported negative net income.
- In the past year ABP has reported a negative cash flow from operations.
1.2 Ratios
- The Return On Assets of ABP (-1294.36%) is worse than 95.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1294.36% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-240.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for ABP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ABP Health Analysis
2.1 Basic Checks
- ABP does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ABP has more shares outstanding
- The debt/assets ratio for ABP is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -131.81, we must say that ABP is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of -131.81, ABP is not doing good in the industry: 94.06% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -131.81 |
ROIC/WACCN/A
WACC5.28%
2.3 Liquidity
- A Current Ratio of 0.07 indicates that ABP may have some problems paying its short term obligations.
- ABP has a Current ratio of 0.07. This is amonst the worse of the industry: ABP underperforms 94.44% of its industry peers.
- A Quick Ratio of 0.07 indicates that ABP may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.07, ABP is doing worse than 94.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.07 | ||
| Quick Ratio | 0.07 |
3. ABP Growth Analysis
3.1 Past
- ABP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -361.99%.
- The Revenue for ABP has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)-361.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.3%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
3.2 Future
- Based on estimates for the next years, ABP will show a very negative growth in Earnings Per Share. The EPS will decrease by -299.48% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-3837.5%
EPS Next 2Y-556.7%
EPS Next 3Y-299.48%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. ABP Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ABP. In the last year negative earnings were reported.
- Also next year ABP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as ABP's earnings are expected to decrease with -299.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-556.7%
EPS Next 3Y-299.48%
5. ABP Dividend Analysis
5.1 Amount
- ABP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ABP Fundamentals: All Metrics, Ratios and Statistics
0.522
-0.28 (-34.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14 2025-11-14/amc
Earnings (Next)N/A N/A
Inst Owners7.1%
Inst Owner Change-99.43%
Ins Owners3.06%
Ins Owner Change0%
Market Cap1.42M
Revenue(TTM)N/A
Net Income(TTM)-22.04M
Analysts45
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.57%
Min EPS beat(2)0.99%
Max EPS beat(2)52.15%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-2900%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-24.36
EYN/A
EPS(NY)-6.97
Fwd EYN/A
FCF(TTM)-3.38
FCFYN/A
OCF(TTM)-3.38
OCFYN/A
SpS0
BVpS-5.94
TBVpS-6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1294.36% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-240.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.07 | ||
| Quick Ratio | 0.07 | ||
| Altman-Z | -131.81 |
F-Score2
WACC5.28%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-361.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49.3%
EPS Next Y-3837.5%
EPS Next 2Y-556.7%
EPS Next 3Y-299.48%
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-465.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-465.35%
OCF growth 3YN/A
OCF growth 5YN/A
ABPRO HOLDINGS INC / ABP Fundamental Analysis FAQ
What is the fundamental rating for ABP stock?
ChartMill assigns a fundamental rating of 0 / 10 to ABP.
What is the valuation status of ABPRO HOLDINGS INC (ABP) stock?
ChartMill assigns a valuation rating of 0 / 10 to ABPRO HOLDINGS INC (ABP). This can be considered as Overvalued.
How profitable is ABPRO HOLDINGS INC (ABP) stock?
ABPRO HOLDINGS INC (ABP) has a profitability rating of 0 / 10.
How financially healthy is ABPRO HOLDINGS INC?
The financial health rating of ABPRO HOLDINGS INC (ABP) is 0 / 10.